December 22, 2024 06:31 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jaipur gas tanker crash: Toll touches 14, 30 critical | Arrest warrant against former cricketer Robin Uthappa over 'PF fraud' | PM Modi emplanes for a visit to Kuwait | German Christmas market car attack leaves 2 dead, Saudi Arabian doctor arrested | India, France come together to build world's largest museum in Delhi's Raisina Hill | Canada, US presented no evidence of Indians' involvement in purported criminal acts: Centre informs Parliament amid 'serious allegations' | Delhi Police Crime Branch to investigate FIR against Rahul Gandhi over Parliament tussle | 11 killed in Jaipur gas tanker crash, several injured critically | Bengaluru techie suicide: Atul Subhash's mother approaches Supreme Court seeking custody of grandson | Narendra Modi, King Charles III discuss climate action and sustainability during telephonic conversation
Bharat Biotech develops oral cholera vaccine Hillchol

Bharat Biotech develops oral cholera vaccine Hillchol

Aug 28, 2024, at 06:46 am

Hyderabad:  Bharat Biotech International Limited (BBIL) has announced the launch of Hillchol (BBV131), a new single-strain Oral Cholera Vaccine (OCV) developed under a license from Hilleman Laboratories, which is funded by Merck, USA, and Wellcome Trust, UK. The vaccine aims to combat cholera.

Latest Headlines
Bharat Biotech develops oral cholera vaccine Hillchol Wed, Aug 28 2024